Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biobehavioral Mechanisms of Fatigue in Patients Treated on NCIC CTG MA.32: A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer

NCT01286233 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT01286233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01286233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biobehavioral Mechanisms of Fatigue in Patients Treated on NCIC CTG MA.32: A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
Lead sponsor
NSABP Foundation Inc
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2011
Completion date
September 30, 2016
Enrollment
394 (actual)
Sites
256

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, depression, fatigue, sleep disorders